Explore the intricacies of the FDA's new classification for DNA-based tests measuring minimal residual disease in hematological malignancies. Learn how the shift to Class II with special controls impacts safety, effectiveness, and patient access, reducing regulatory...
Legal and Law Enforcement
Showing 37–45 of 267 resultsSorted by latest
-
U.S. Investments and National Security: Compliance with 31 CFR Part 850
$199.99 -
DFARS Disclosure of Foreign Obligations Course
$49.99 -
Federal Acquisition Regulation: Unmanned Aircraft Systems Prohibition
$49.99 -
GSA’s Proposed Amendments to GSAR for Construction Labor
$49.99 -
TWIC Reader Compliance: Navigating New Deadlines
$49.99 -
Safeguard Tribal Objects of Patrimony (STOP) Act: Proposed Regulatory Framework
$49.99 -
Small Business Contracting: Proposed Rule Overview
$49.99 -
Regulatory Insights on DHS’s REAL ID Waiver for Mobile Licenses
$129.99 -
Amendments to ITAR: USML Categories IV and XV
$49.99